Ameliorating Cardiovascular Risk in Patients with Type 2 Diabetes

被引：4
|
作者：
Motairek, Issam [1 ]
Al-Kindi, Sadeer [1 ]
机构：
[1] Case Western Reserve Univ, Univ Hosp Harrington Heart & Vasc Inst, Sch Med, 11100 Euclid Ave, Cleveland, OH 44106 USA
来源：
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2023年 / 52卷 / 01期
关键词：
Cardiovascular disease; Type 2 diabetes mellitus; Risk factors; PRIMARY PREVENTION; GLYCEMIC CONTROL; DISEASE; OUTCOMES; THERAPY; ADULTS; INTERVENTIONS; COMPLICATIONS; METAANALYSIS; ASSOCIATION;
D O I：
10.1016/j.ecl.2022.07.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：135 / 147
页数：13
相关论文
共 50 条
  • [31] Dietary management of cardiovascular risk including type 2 diabetes
    Nestel, Paul J.
    Sullivan, David R.
    Mori, Trevor A.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2021, 28 (02) : 134 - 141
  • [32] Uncovering actionable cardiovascular risk subgroups in type 2 Diabetes: A latent class analysis
    Geurten, Rose J.
    Hameleers, Niels
    Struijs, Jeroen N.
    Bilo, Henk J. G.
    Ruwaard, Dirk
    Elissen, Arianne M. J.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2025, 222
  • [33] Adiponectin, type 2 diabetes and cardiovascular risk
    Lindberg, Soren
    Jensen, Jan Skov
    Bjerre, Mette
    Pedersen, Sune H.
    Frystyk, Jan
    Flyvbjerg, Allan
    Galatius, Soren
    Jeppesen, Jorgen
    Mogelvang, Rasmus
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2015, 22 (03) : 276 - 283
  • [34] Chronic kidney disease and cognitive decline in patients with type 2 diabetes at elevated cardiovascular risk
    Verhagen, Chloe
    Janssen, Jolien
    Minderhoud, Crista A.
    van den Berg, Esther
    Wanner, Christoph
    Passera, Anna
    Johansen, Odd Erik
    Biessels, Geert Jan
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2022, 36 (10)
  • [35] Electronic Medical Record Risk Modeling of Cardiovascular Outcomes Among Patients with Type 2 Diabetes
    Hong, Dongzhe
    Fort, Daniel
    Shi, Lizheng
    Price-Haywood, Eboni G.
    DIABETES THERAPY, 2021, 12 (07) : 2007 - 2017
  • [36] Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: A meta-analysis
    Zhang, Chun-Yu
    Sun, Ai-Jun
    Zhang, Shu-Ning
    Wu, Chao-Neng
    Fu, Ming-Qiang
    Xia, Guang
    Wang, Ke-Qiang
    Zou, Yun-Zeng
    Ge, Jun-Bo
    ANNALS OF MEDICINE, 2010, 42 (04) : 305 - 315
  • [37] Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
    Htay, Thwe
    Soe, Kyaw
    Lopez-Perez, Arianna
    Amy HoangAnh Doan
    Romagosa, Michael A.
    Aung, KoKo
    CURRENT CARDIOLOGY REPORTS, 2019, 21 (06)
  • [38] Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
    Rawshani, Aidin
    Rawshani, Araz
    Franzen, Stefan
    Eliasson, Bjorn
    Svensson, Ann-Marie
    Miftaraj, Mervete
    McGuire, Darren K.
    Sattar, Naveed
    Rosengren, Annika
    Gudbjornsdottir, Soffia
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (15) : 1407 - 1418
  • [39] Cardiovascular risk and the implications for clinical practice of cardiovascular outcome trials in type 2 diabetes
    Chilton, Robert J.
    Dungan, Kathleen M.
    Shubrook, Jay H.
    Umpierrez, Guillermo E.
    PRIMARY CARE DIABETES, 2020, 14 (03) : 193 - 212
  • [40] Racial/ethnic differences in control of cardiovascular risk factors among type 2 diabetes patients in an insured, ambulatory care population
    Holland, Ariel T.
    Zhao, Beinan
    Wong, Eric C.
    Choi, Sarah E.
    Wong, Nathan D.
    Palaniappan, Latha P.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2013, 27 (01) : 34 - 40
12345